Iga Swiatek, the World No. 2 tennis player, addressed the drugs scandal that recently emerged, saying she is ready to move on and insists there is no reason for the World Anti-Doping Agency (WADA) to appeal her case.
Swiatek tested positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August while she was ranked No. 1. The International Tennis Integrity Agency (ITIA) accepted that the violation was unintentional, resulting in a one-month suspension that caused her to miss three tournaments in Asia and lose her top ranking.
Swiatek acknowledged that the ordeal was mentally challenging, but she has been reassured by the positive public response. She emphasized that most people understood the situation, especially those familiar with the details and the workings of the anti-doping system.
Swiatek explained that she had no influence on the contamination and is focused on moving forward, preparing for the season, and concentrating on her tennis career. She will return to competition at the United Cup in Sydney ahead of the Australian Open next month.
In drawing a parallel to Jannik Sinner’s case, Swiatek expressed confidence that WADA will not appeal her case, as she has provided all necessary evidence to clarify the situation. Despite the abstract nature of the process and the legal complexities involved, Swiatek felt that the process was fair and was satisfied with how the ITIA handled her case. She noted that providing the source of the contamination promptly helped bring the case to a swift resolution.
ADD A COMMENT :